Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Itopride Hydrochloride 50 mg Film-coated Tablets in Healthy Thai Volunteers
TCTR20260329004Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of itopride in functional dyspepsia (FD) (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic endpoints. Planned start May 2026; status: not yet recruiting.
02
Drugs
itopride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on TCTR20260329004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260329004.